TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
+7.45%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$752M
AUM Growth
+$752M
(+3.6%)
Cap. Flow
-$7.37M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
43.11%
Holding
80
New
2
Increased
27
Reduced
31
Closed
4
Top Buys
| 1 |
Brown-Forman Class B
BF.B
|
$1.02M |
| 2 |
Illinois Tool Works
ITW
|
$797K |
| 3 |
Mettler-Toledo International
MTD
|
$718K |
| 4 |
United Parcel Service
UPS
|
$621K |
| 5 |
Verizon
VZ
|
$421K |
Top Sells
| 1 |
Kimberly-Clark
KMB
|
$6.62M |
| 2 |
Fortive
FTV
|
$3.07M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$2.55M |
| 4 |
General Mills
GIS
|
$996K |
| 5 |
Unilever
UL
|
$908K |
Sector Composition
| 1 | Healthcare | 47.03% |
| 2 | Technology | 10.37% |
| 3 | Industrials | 9.39% |
| 4 | Consumer Discretionary | 6.32% |
| 5 | Financials | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIF
1
DELISTED
Tiffany & Co.
TIF
| $44.8M | 5.95% |
340,190
-2,146
| -0.6% | -$282K |
|
2
Neogen
NEOG
$1.25B
| $36.6M | 4.86% |
456,030
-2,816
| -0.6% | -$226K |
|
3
Cognex
CGNX
$7.38B
| $33.1M | 4.4% |
741,675
+2,275
| +0.3% | +$101K |
|
4
Idexx Laboratories
IDXX
$51.8B
| $33M | 4.38% |
151,280
-1,950
| -1% | -$425K |
|
5
Analog Devices
ADI
$124B
| $31.9M | 4.24% |
332,845
+1,150
| +0.3% | +$110K |
|
6
Mastercard
MA
$538B
| $30.6M | 4.07% |
155,666
+51
| +0% | +$10K |
|
7
Inogen
INGN
$216M
| $30.6M | 4.06% |
164,115
-3,800
| -2% | -$708K |
|
|
ABMD
8
DELISTED
Abiomed Inc
ABMD
| $30.2M | 4.02% |
73,940
-6,240
| -8% | -$2.55M |
|
9
DexCom
DXCM
$29.5B
| $27.6M | 3.66% |
290,204
+375
| +0.1% | +$35.6K |
|
10
Insulet
PODD
$23.9B
| $26.1M | 3.46% |
304,165
+1,125
| +0.4% | +$96.4K |
|
|
RTN
11
DELISTED
Raytheon Company
RTN
| $25.9M | 3.44% |
134,139
+817
| +0.6% | +$158K |
|
|
12
Brown-Forman Class B
BF.B
$14.2B
| $24.5M | 3.26% |
500,364
+20,828
| +4% | +$1.02M |
|
13
Danaher
DHR
$147B
| $24.3M | 3.23% |
246,501
-234
| -0.1% | -$23.1K |
|
14
Johnson & Johnson
JNJ
$427B
| $23.9M | 3.18% |
197,245
+954
| +0.5% | +$116K |
|
15
Honeywell
HON
$139B
| $22.9M | 3.04% |
158,944
+277
| +0.2% | +$39.9K |
|
16
Biogen
BIIB
$19.4B
| $20.7M | 2.75% |
71,357
-870
| -1% | -$253K |
|
17
Novo Nordisk
NVO
$251B
| $18.8M | 2.5% |
407,445
+1,450
| +0.4% | +$66.9K |
|
18
Ross Stores
ROST
$48.1B
| $18.6M | 2.48% |
219,759
-1,224
| -0.6% | -$104K |
|
19
Starbucks
SBUX
$100B
| $15.8M | 2.1% |
323,738
-7,635
| -2% | -$373K |
|
20
Henry Schein
HSIC
$8.44B
| $14.5M | 1.92% |
199,163
+2,100
| +1% | +$153K |
|
21
Amgen
AMGN
$155B
| $14.1M | 1.88% |
76,445
-579
| -0.8% | -$107K |
|
|
NVRO
22
DELISTED
NEVRO CORP.
NVRO
| $13.8M | 1.84% |
173,170
+4,365
| +3% | +$349K |
|
|
23
Mettler-Toledo International
MTD
$26.8B
| $13.5M | 1.8% |
23,350
+1,240
| +6% | +$718K |
|
24
AbbVie
ABBV
$372B
| $11.5M | 1.52% |
123,700
-850
| -0.7% | -$78.8K |
|
25
State Street
STT
$32.6B
| $10.8M | 1.44% |
116,308
+2,049
| +2% | +$191K |
|